A pharmacological study showed that JPJD drastically inhibited the tumor invasive and migratory capability by inhibition of TGF-β/Smad signaling pathway, then modulating the EMT-related signatures containing Snail, E-cadherin, and vimentin expression levels. Here, TGFB1 is linked to neoplasm.